Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by Sp1

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3215-3222

  Steinke, John W ^a,d   Barekzi, Elizabeth ^a   Hagman, James ^b,c   Borish, Larry ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SEQUENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REPRESSOR GENE; TRANSCRIPTION REGULATION;

EID: 4344623872     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3215     Document Type: Article

References (64)

1. Borish, L. C., and J. W. Steinke. 2003. Cytokines and chemokines. J. Allergy Clin. Immunol. 111:S460.
2. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
3. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J. Immunol. 150:4754.
4. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
5. de Waal Malefyt, R. D., J. S. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
6. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853.
7. + T cell clones and peripheral blood T cells. J. Immunol. 149:2378.
8. Akdis, C. A., T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser. 1998. The role of IL-10 in specific immunotherapy. J. Clin. Invest. 102:98.
9. Mason, D., and F. Powrie. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10:649.
10. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunedeficiency B cells. J. Exp. Med. 172:1625.
11. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944.
12. de Saint-Vis, B., I. Fuigier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervliet, S. Ait-Yahia, J. Banchereau, Y. J. Liu, S. Lebecque, and C. Caux. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160:1666.
13. Thompson-Snipes, L., V. Dahr, M. W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173:507.
14. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 147:2815.
15. Ralph, P., I. Nakoinz, A. Sampson-Johannes, S. Fong, D. Lowe, H. Y. Min, and L. Lin. 1992. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol. 148:808.
16. Bogdan, C., Y. Vodoyotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
17. D'Andrea, A., M. Aste-Amezaga, N. M. Vaiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
18. de Waal Malefyt, R. D., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. G. Figdor, K. Johnsbn, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
19. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 151:2390.
20. Becker, J. C., C. Czerny, and E. B. Brocker. 1994. Maintenance of clonal anergy by endogenously produced IL-10. Int. Immunol. 6:1605.
21. Takanaski, S., R. Nonaka, Z. Xing, P. O'Bryne, J. Dolovich, and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180:711.
22. Punnonen, J., R. D. Malefyt, P. Van Vlasselaer, J.-F. Gauchat, and J. E. de Vries. 1993. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 151:1280.
23. Akdis, C. A., and K. Blaser. 1999. IL-10-induced anergy in peripheral T cell and reactivation by microenviromental cytokines: two key steps in specific immunotherapy. FASEB J. 13:603.
24. Akbari, O., R. H. DeKruyff, and D. T, Umtesu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725.
25. Marsh, D. G., J. D. Neely, D. R. Breazeale, B. Ghosh, L. R. Freidhoff, E. Ehrlich-Kautzky, C. Schou, G. Krishnaswamy, and T. H. Beaty. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152.
26. Meyers, D. A., D. S. Postma, C. I. M. Panhuysen, J. Xu, P. J. Amelung, R. C. Levitt, and E. R. Bleecker. 1994. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23:464.
27. Rosenwasser, L. J., D. J. Klemm, J. K. Dresback, H. Inamura, J. J. Mascali, M. Klinnert, and L. Borish. 1995. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy 25:74.
28. Hobbs, K., J. Negri, M. Klinnert, L. J. Rosenwasser, and L. Borish. 1998. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am. J. Respir. Crit. Care Med. 158:1958.
29. Immervoll, T., S. Loesgen, G. Dutsch, H. Gohlke, N. Herbon, S. Klugbauer, A. Dempfle, H. Bickeboller, J. Becker-Follmann, F. Ruschendorf, et al. 2001. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum. Mutat. 18:327.
30. Hajeer, A, H., M. Lazrus, D. Turner, R. A. Mageed, J. Vencovsky, P. Sinnott, I. V. Hutchinson, and W. E. R. Ollier. 1998. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand. J. Rheumatol. 27:142.
31. Eskdale, J., P. Wordsworth, S. Bowman, M. Field, and G. Gallagher. 1997. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 49:635.
32. Mok, C. C., J. S. Lanchbury, D. W. Chan, and C. S. Lau. 1998. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090.
33. Lazarus, M., A. H. Hajeer, D. Turner, P. Sinnott, J. Worthington, W. E. R. Ollier, and I. V. Hutchinson. 1997. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol. 24:2314.
34. MacDonald, T. T. 1994. Gastrointestinal inflammation: inflammatory bowel disease in knockout mice. Curr. Biol. 4:261.
35. Middleton, P. G., P. R. Taylor, G. Jackson, S. J. Proctor, and A. M. Dickinson. 1998. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 92:3943.
36. Shin, H. D., C. Winkler, J. C. Stephens, J. Bream, H. Young, J. J. Goedert, T. R. O'Brien, D. Vlahov, S. Buchbinder, J. Giorgi, et al. 2000. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl. Acad. Sci. USA 97:14467.
37. Hagman, J., A. Travis, and R. Grosschedl. 1991. A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation. EMBO J. 10:3409.
38. Fitzsimmons, D., W. Hodson, W. Wheat, S. M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198.
39. Stewart, J. P., F. G. Behm, J. R. Arrand, and C. M. Rooney. 1994. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 200:724.
40. Brightbill, H. D., S. E. Plevy, R. L. Modlin, and S. T. Smale. 2000. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164:1940.
41. Tone, M., M. J. Powell, Y. Tone, S. A. J. Thompson, and H. Waldmann. 2000. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 165:286.
42. Shewey, L. M., J. S. Beaty, L. C. Andersen, and G. T. Nepom. 1992. Differential expression of related HLA class II DQ β genes caused by nucleotide variation in transcriptional regulatory elements. J. Immunol. 148:1265.
43. Emery, P., B. Mach, and W. Reith. 1993. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum. Immunol. 38:137.
44. LeVan, T. D., J. W. Bloom, T. J. Bailey, C. L. Karp, M. Halonen, F. D. Martinez, and D. Vercelli. 2001. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167:5838.
45. Nickel, R. G., V. Caslaro, U. Wahn, K. Beyer, K. C. Barnes, B. S. Plunkett, L. R. Freidhoff, C. Sengler, J. R. Plitt, R. P. Schleimer, et al. 2000. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 164:1612.
46. Yao, T., M. Kuo, L. See, L. Chen, D. Yan, L. Ou, C. Shaw, and I. Huang. 2003. The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J. Allergy Clin. Immunol. 111:1285.
47. Dittmer, J., A. Gegonne, S. D. Gitlin, J. Ghysdael, and J. N. Brady. 1994. Regulation of parathyroid hormone-related protein (PTHrP) gene expression. J.f Biol. Chem. 269:21428.
48. Kuhn, R., J. Lohler, D. M. Rennick, K. Rajeswky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
49. Rennick, D., N. Davidson, and D. Berg. 1995. Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin. Immunol. Immunopathol. 76:S174.
50. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
51. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. I. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, T. Sano, et al. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927.
52. Gibson, A. W., J. C. Edberg, J. Wu, R. G. J. Westendorp, T. W. J. Huizinga, and R. P. Kimberly. 2001. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166:3915.
53. + T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103:449.
54. Jones, E. A., J. H. Pringle, C. A. Angel, and R. C. Rees. 2002. Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL). Leuk. Lymphoma 43:1313.
55. Aydin, F., M. Yilmaz, F. Ozdemir, H. Kavgaci, M. N. Yavuz, and A. A. Yavuz. 2002. Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma. Am. J. Clin. Oncol. 25:570.
56. Cunningham, L. M., C. Chapman, R, Dunstan, M. C. Bell, and D. J. Joske. 2003. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma. Leuk. Lymphoma 44:251.
57. Houssiau, F. A., C. Lefebvre, M. Vanden Berghe, M. Lambert, J. P. Devogelaer, and J. C. Renauld. 1995. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4:393.
58. Cohen, S. B., P. D. Katsikis, C. Q. Chu, H. Thomssen, L. M. Webb, R. N. Maini, M. Londei, and M. Feldman. 1995. High levels of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 38:946.
59. D'Alfonso, S., M. Rampi, D. Bocchio, G. Colombo, R. Scorza-Smeraldi, and P. Momigliano-Richardi. 2000. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum. 43:120.
60. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
61. Borish, L., A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel. 1996. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97:1288.
62. Robinson, D. S., A. Tsicopoulos, Q. Meng, S. Durham, A. B. Kay, and Q. Hamid. 1996. Increased interlukin-10 mRNA expression in atopic allergy and asthma. Am. J. Respir. Cell. Mol. Biol. 14:113.
63. Ohmen, J. D., J. M. Hanifin, B. J. Nickoloff, T. H. Rea, R. Wyzykowski, J. Kim, D. Jullien, T. McHugh, A. S. Nassif, S. C. Chan, et al. 1995. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1956.
64. Karjalainen, J., J. Hulkkonen, M. M. Nieminen, H. Huhtala, A. Aromaa, T. Klaukka, and M, Hurme. 2003. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin. Exp. Allergy 33:78.